Principal investigators and academic institutions across New Mexico require reliable, verified sources for high-purity coenzymes and signaling molecules. PX1 Research supplies USA-synthesized, HPLC/MS-verified NAD+ directly to laboratories in Albuquerque, Las Cruces, Santa Fe, and surrounding research hubs. Fulfilling orders from optimized facilities in California and Arizona, we eliminate international customs delays while maintaining strict ISO 17025 quality standards.
Principal investigators and academic institutions across New Mexico require reliable, verified sources for high-purity coenzymes and signaling molecules. PX1 Research supplies USA-synthesized, HPLC/MS-verified NAD+ directly to laboratories in Albuquerque, Las Cruces, Santa Fe, and surrounding research hubs. Fulfilling orders from optimized facilities in California and Arizona, we eliminate international customs delays while maintaining strict ISO 17025 quality standards.
Biomedical and biochemical research across New Mexico—spanning major state university facilities, national laboratories, and private biotechnology centers—demands rigorous material controls and reproducible reference standards. Nicotinamide Adenine Dinucleotide (NAD+) serves as a critical coenzyme in cellular redox reactions, energy metabolism, and genomic stability assays. When purchasing research-grade NAD+ for in vitro or animal models, investigators must prioritize analytical purity, batch consistency, and reliable supply chains to safeguard trial integrity.
PX1 Research addresses these strict institutional demands by supplying USA-synthesized compounds directly to New Mexico research centers. Because domestic shipping originates from nearby fulfillment centers in Arizona and California, orders arrive rapidly without the customs bottlenecks, customs inspections, or degradation risks associated with overseas suppliers. Every lot undergoes thorough testing in ISO 17025 accredited facilities, ensuring that laboratory personnel receive verified materials tailored specifically for advanced analytical work.
Nicotinamide Adenine Dinucleotide (C21H27N7O14P2) is a dinucleotide compound consisting of two phosphate groups joined by a phosphoanhydride bond, connecting an adenine nucleoside to a nicotinamide nucleoside. In cellular systems, NAD+ exists in two main forms: the oxidized state (NAD+) and the reduced state (NADH). The oxidized form functions as a key electron acceptor in metabolic pathways such as glycolysis, the citric acid cycle (TCA), and mitochondrial beta-oxidation.
In preclinical studies, researchers analyze the stoichiometry of the NAD+/NADH ratio to evaluate cellular metabolic health, respiratory chain efficiency, and oxidative state. Because NAD+ acts as a required co-substrate for enzymes like sirtuins, poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38), maintaining precise chemical purity in exogenous NAD+ preparations is vital. Contaminants or degradation products like free nicotinamide can act as enzymatic inhibitors, confounding baseline measurements in enzymatic kinetic assays.
A primary focus of current metabolic research involves how intracellular pools of NAD+ modulate sirtuin signaling pathways (SIRT1–SIRT7). Sirtuins are NAD+-dependent deacetylases that regulate chromatin remodeling, transcription factor activity, and mitochondrial biogenesis. Preclinical rodent models demonstrate that altered NAD+ availability directly impacts SIRT1 mediated deacetylation of PGC-1 alpha, a central regulator of mitochondrial function.
In vitro data indicate that elevated cellular NAD+ levels promote mitochondrial protein synthesis, enhance oxidative phosphorylation rates, and attenuate mitochondrial reactive oxygen species (ROS) production. Investigators evaluating age-related metabolic decline or neurodegenerative disease models utilize pure NAD+ research peptide solutions to map how salvage pathway enzymes (such as NAMPT) maintain cellular viability under induced metabolic stressors. Reviewing studies in our preclinical research library provides further mechanistic context on coenzyme signaling cascades.
Beyond metabolic electron transfer, NAD+ serves as the sole substrate for Poly(ADP-ribose) Polymerases (PARPs), specifically PARP1 and PARP2. These nuclear enzymes detect single-strand DNA breaks and catalyze the transfer of ADP-ribose moieties from NAD+ onto target proteins, recruiting cellular DNA repair machinery to sites of damage.
In cell culture assays, intense DNA damage leads to rapid consumption of intracellular NAD+ by overactivated PARP enzymes, resulting in ATP depletion and metabolic collapse. Researchers studying DNA damage response, radiation biology, and oncogenic signaling frequently manipulate exogenous NAD+ pools to observe whether coenzyme supplementation restores genomic integrity or influences cell death pathways (apoptosis versus necrosis) in cell-line models.
For findings to hold up to peer review, research reagents must meet stringent purity specifications. PX1 Research subjects every synthesized lot of NAD+ to comprehensive analytical verification. High-Performance Liquid Chromatography (HPLC) is utilized to confirm chemical purity, guaranteeing that every lot meets or exceeds a >98% threshold. Mass Spectrometry (MS) is simultaneously performed to verify exact molecular weight and structural identity, ensuring the absence of structural isomers or synthetic byproducts.
In addition to purity and identity confirmation, strict endotoxin testing is performed via Chromogenic LAL assays. Endotoxins (lipopolysaccharides) can trigger non-specific inflammatory signaling in primary cell cultures and live animal models, severely distorting immunological and metabolic data. PX1 Research certifies that all delivered batches contain <0.01 EU/mg of endotoxin, providing peace of mind for sensitive in vitro and in vivo protocols.
Procuring research compounds from international brokers introduces severe risks, including variable transit times, temperature exposure, customs clearance delays, and questionable batch testing. PX1 Research mitigates these risks by maintaining centralized warehousing and distribution facilities in California and Arizona. This geographic proximity ensures expedited ground and air transport directly to New Mexico destinations, including Albuquerque, Santa Fe, Las Cruces, and Los Alamos.
Orders placed Monday through Friday before cut-off times are dispatched the same day. By reducing shipping duration to 1–2 business days across the Desert Southwest, temperature-sensitive compounds retain structural integrity. Furthermore, eliminate customs documentation hurdles and guarantee that every order is accompanied by a batch-specific Certificate of Analysis (COA) directly downloadable prior to assay deployment.
When designing cellular metabolism protocols, researchers often compare direct NAD+ administration against intermediate precursors in the salvage pathway. Three primary compounds dominate this space: direct NAD+ powder, nicotinamide mononucleotide (NMN), and nicotinamide riboside (NR). Understanding the cellular uptake kinetics of each coenzyme form allows investigators to tailor experimental models appropriately.
While direct NAD+ has traditionally been evaluated in cell-free enzymatic assays and extracellular signaling studies, precursors like NMN and NR are frequently utilized to evaluate intracellular transport mechanisms via specific transporters (e.g., Slc12a8 for NMN). However, recent in vitro research demonstrates that extracellular NAD+ can be cleaved into precursors or imported directly via specialized membrane channels in select cell types. Combining these compounds in comparative assays provides a comprehensive picture of NAD+ homeostasis and sirtuin pathway kinetics.
To preserve the integrity of lyophilized NAD+ upon arrival in the laboratory, strict handling protocols must be observed. Lyophilized NAD+ powder should be stored at -20°C in a dry, dark environment to prevent hygroscopic moisture absorption and slow spontaneous hydrolysis into nicotinamide and ADP-ribose.
When reconstituting for in vitro assays, sterile, deionized, or phosphate-buffered saline (PBS) free from nucleases should be utilized under a laminar flow hood. Once reconstituted into aqueous solution, NAD+ is relatively unstable at room temperature; working aliquots should be used immediately or frozen at -80°C to minimize degradation over freeze-thaw cycles. Laboratories requiring high-volume reagents for ongoing multi-well screens can establish wholesale institutional accounts to ensure a steady supply of fresh, lot-matched materials.
PX1 Research supports university departments, core facilities, and independent biotechnology companies across New Mexico with tailored procurement solutions. We understand the administrative and compliance needs of academic purchase orders, grant-funded acquisitions, and standard operational account management.
Whether setting up routine standing orders or requesting large-scale custom synthesis, institutional buyers receive dedicated account oversight, volume tier pricing, and guaranteed lot reservation. This ensures long-term experimental continuity without the variance introduced by switching suppliers mid-project.
How quickly do NAD+ research peptide orders arrive in New Mexico?
Because PX1 Research dispatches orders directly from fulfillment hubs in Arizona and California, shipments to New Mexico (including Albuquerque, Santa Fe, and Las Cruces) typically arrive within 1 to 2 business days via standard expedited ground or express air. All orders placed Monday through Friday before 3:00 PM PST are shipped same-day.
What analytical documentation is provided with PX1 NAD+ shipments?
Every lot of NAD+ supplied by PX1 Research includes a batch-specific Certificate of Analysis (COA). This documentation features High-Performance Liquid Chromatography (HPLC) purity traces, Mass Spectrometry (MS) structural identification, and Chromogenic LAL endotoxin testing results.
Can New Mexico university laboratories set up wholesale accounts?
Yes. PX1 Research offers institutional accounts for academic research departments, government labs, and commercial facilities in New Mexico. Qualified buyers can access volume pricing, dedicated lot reservations, and institutional purchase order invoicing through our wholesale portal.
Is NAD+ provided by PX1 intended for clinical or therapeutic use?
No. All compounds provided by PX1 Research, including NAD+, are strictly manufactured and sold for laboratory research use only (in vitro and preclinical models). They are not intended for human or animal therapeutic use, clinical administration, or medical diagnosis.
What are the recommended storage parameters for lyophilized NAD+?
Lyophilized NAD+ should be stored at -20°C in a desiccated environment protected from light. Reconstituted stock solutions should be divided into single-use working aliquots and stored at -80°C to prevent degradation from freeze-thaw cycles.
What endotoxin threshold does PX1 guarantee for research-grade NAD+?
PX1 Research guarantees an endotoxin limit of less than 0.01 EU/mg for all research-grade NAD+ batches, confirmed via LAL assay testing, ensuring suitability for sensitive cell culture and preclinical models.
How does direct NAD+ compare to precursor compounds in research assays?
Direct NAD+ is ideal for enzymatic kinetic assays, cell-free sirtuin/PARP reaction setups, and extracellular pathway research. Precursors like NMN and NR are often chosen to investigate specific cell-membrane transport channels and intracellular salvage pathway kinetics.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.